Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine in cold blood cardioplegia during mitral valve surgery
IRCT2016061428454N1Phase 3Completed
- Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Start
- Dec 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of adenosine in mitral valve disease (2 arms), sponsored by Rajaie Cardiovascular Medical and Research Center. Primary endpoint: TNF-α. Started Dec 2018; status: completed.
02
Drugs
adenosine
03
Conditions
mitral valve disease
Beyond the preview
Go deeper on IRCT2016061428454N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016061428454N1.